Brands; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brands; Michael.The latest application filed is for "pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis".

Company Profile

0.8.16

Brands; Michael - Berlin N/A DE
Brands; Michael - Wuppertal DE
Brands; Michael - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted tricyclic compounds and methods of use thereof Grant 8,524,722 - Schirok , et al. September 3, 2	2013-09-03
Pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20130225809 - Dixon; Julie A. ; et al.	2013-08-29
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,338,595 - Dixon , et al. December 25, 2	2012-12-25
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders App 20110098301 - Dixon; Julie A. ; et al.	2011-04-28
Substituted Tricyclic Compounds And Methods Of Use Thereof App 20110021493 - Schirok; Hartmut ; et al.	2011-01-27
Pyrimidine Derivatives For Treatment Of Hyperproliferative Disorders App 20100075967 - Dixon; Julie A. ; et al.	2010-03-25
Pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20100075958 - Dixon; Julie A. ; et al.	2010-03-25
Pyrimidine derivatives for treatment of hyperproliferative disorders Grant 7,678,804 - Dixon , et al. March 16, 2	2010-03-16
Pyrimidine Derivatives App 20090286785 - Nagarathnam; Dhanapalan ; et al.	2009-11-19
Pyrimidine Derivatives App 20090258888 - Nagarathnam; Dhanapalan ; et al.	2009-10-15
Pyrimidine derivatives for treatment of hyperproliferative disorders Grant 7,582,645 - Dixon , et al. September 1, 2	2009-09-01
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 7,563,791 - Dixon , et al. July 21, 2	2009-07-21
Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis App 20070208013 - Dixon; Julie A. ; et al.	2007-09-06
Pyrimidine derivatives for treatment of hyperproliferative disorders App 20070117817 - Dixon; Julie A. ; et al.	2007-05-24
Use of substituted 2,5-diamidoindoles for the treatment of urological diseases App 20060183753 - Erguden; Jens ; et al.	2006-08-17
Uracil-thioether App 20060122201 - Svenstrup; Niels ; et al.	2006-06-08
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases Grant 7,045,544 - Erguden , et al. May 16, 2	2006-05-16
Piperidine ouracil used as a medicament for treating bacterial infections App 20060100224 - Svenstrup; Niels ; et al.	2006-05-11
Pyrimidine derivatives for treatment of hyperproliferative disorders App 20050277640 - Dixon, Julie A. ; et al.	2005-12-15
Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases App 20050038101 - Erguden, Jens-Kerim ; et al.	2005-02-17
Medicament for viral diseases App 20030187028 - Brands, Michael ; et al.	2003-10-02
Tan-1057 derivatives Grant 6,617,332 - Brands , et al. September 9, 2	2003-09-09
Medicaments for viral diseases App 20020082264 - Nikolic, Susanne ; et al.	2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.